Ricardo Grieshaber-Bouyer

Mr. Ricardo Grieshaber-Bouyer


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2017 in Blood
Verified
Journal Article
Open access
PDF file
MBMing Bai
Ming Bai
RGRicardo Grieshaber-Bouyer
Ricardo Grieshaber-Bouyer
JWJunxia Wang
Junxia Wang
ASAngela B. Schmider
Angela B. Schmider
ZWZachary S. Wilson
Zachary S. Wilson
PNPeter A. Nigrovic
Peter A. Nigrovic
Key Points: Ligation of CD177, a GPI-linked surface protein expressed selectively on neutrophils, blocks neutrophil migration independently of PECAM-1. Blockade reflects activation through β2 integrins, immobilizing cells via stronger integrin attachments and impaired chemokine signaling.

26 April 2024 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
LBLaura Bucci
Laura Bucci
MHMelanie Hagen
Melanie Hagen
TRTobias Rothe
Tobias Rothe
MRMaria Gabriella Raimondo
Maria Gabriella Raimondo
FFFilippo Fagni
Filippo Fagni
RGRicardo Grieshaber-Bouyer
Ricardo Grieshaber-Bouyer

4 March 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
RGRicardo Grieshaber-Bouyer
Ricardo Grieshaber-Bouyer
PNPeter A. Nigrovic
Peter A. Nigrovic
Neutrophils are versatile innate effector cells essential for immune defense but also responsible for pathologic inflammation. This dual role complicates therapeutic targeting. However, neither neutrophils themselves nor the mechanisms they employ in different forms of immune responses are homogeneous, offering possibilities for selective intervention. Here we review heterogeneity within the neutrophil population as well as in the pathways mediating neutrophil recruitment to inflamed tissues with a view to outlining opportunities for therapeutic manipulation in inflammatory disease.

5 September 2024 in New England Journal of Medicine
Verified
Journal Article
Closed access
MHMelanie Hagen
Melanie Hagen
LBLaura Bucci
Laura Bucci
SBSebastian Böltz
Sebastian Böltz
DNDanae-Mona Nöthling
Danae-Mona Nöthling
TRTobias Rothe
Tobias Rothe
RGRicardo Grieshaber-Bouyer
Ricardo Grieshaber-Bouyer

1 October 2021 in Cell Reports
Verified
Journal Article
Open access
MCMargaret H. Chang
Margaret H. Chang
ALAnaïs Levescot
Anaïs Levescot
NNNathan Nelson-Maney
Nathan Nelson-Maney
RBRachel B. Blaustein
Rachel B. Blaustein
KWKellen D. Winden
Kellen D. Winden
PNPeter A. Nigrovic
Peter A. Nigrovic
Rheumatoid arthritis is a systemic autoimmune disease, but disease flares typically affect only a subset of joints, distributed in a distinctive pattern for each patient. Pursuing this intriguing pattern, we show that arthritis recurrence is mediated by long-lived synovial resident memory T cells (TRM). In three murine models, CD8+ cells bearing TRM markers remain in previously inflamed joints during remission. These cells are bona fide TRM, exhibiting a failure to migrate between joints, preferential uptake of fatty acids, and long-term residency. Disease flares result from TRM activation by antigen, leading to CCL5-mediated recruitment of circulating effector cells. Correspondingly, TRM depletion ameliorates recurrence in a site-specific manner. Human rheumatoid arthritis joint tissues contain a comparable CD8+-predominant TRM population, which is most evident in late-stage leukocyte-poor synovium, exhibiting limited T cell receptor diversity and a pro-inflammatory transcriptomic signature. Together, these findings establish synovial TRM as a targetable mediator of disease chronicity in autoimmune arthritis.

8 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
NHNicolaj S. Hackert
Nicolaj S. Hackert
FRFelix Andreas Radtke
Felix Andreas Radtke
TETarik Exner
Tarik Exner
HLHanns-Martin Lorenz
Hanns-Martin Lorenz
CMCarsten Müller-Tidow
Carsten Müller-Tidow
RGRicardo Grieshaber-Bouyer
Ricardo Grieshaber-Bouyer
Neutrophils are frequently studied in mouse models, but the extent to which findings translate to humans remains poorly defined. In an integrative analysis of 11 mouse and 13 human datasets, we find a strong correlation of neutrophil gene expression across species. In inflammation, neutrophils display substantial transcriptional diversity but share a core inflammation program. This program includes genes encoding IL-1 family members, CD14, IL-4R, CD69, and PD-L1. Chromatin accessibility of core inflammation genes increases in blood compared to bone marrow and further in tissue. Transcription factor enrichment analysis implicates members of the NF-κB family and AP-1 complex as important drivers, and HoxB8 neutrophils with JunB knockout show a reduced expression of core inflammation genes in resting and activated cells. In independent single-cell validation data, neutrophil activation by type I or type II interferon, G-CSF, and E. coli leads to upregulation in core inflammation genes. In COVID-19 patients, higher expression of core inflammation genes in neutrophils is associated with more severe disease. In vitro treatment with GM-CSF, LPS, and type II interferon induces surface protein upregulation of core inflammation members. Together, we demonstrate transcriptional conservation in neutrophils in homeostasis and identify a core inflammation program shared across heterogeneous inflammatory conditions.